Despite not being approved in Europe as first-line therapy, the efavirenz (EFV)-containing single tablet regimen (STR) is frequently used in clinical practice in naïve patients but few data are available on this strategy. In our study, we aimed to assess the risk of EFV discontinuation in patients starting antiretroviral therapy with STR vs. nonSTR.
Fabbiani, M., Zaccarelli, M., Latini, A., Sterrantino, G., D'Ettorre, G., Grima, P., Mondi, A., Rossetti, B., Borchi, B., Giuliani, M., Antinori, A., De Luca, A., Di Giambenedetto, S., Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen, <<HIV MEDICINE>>, 2015; (Settembre): N/A-N/A. [doi:10.1111/hiv.12313] [http://hdl.handle.net/10807/68426]
Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen
Fabbiani, Massimiliano;Mondi, Annalisa;Rossetti, Barbara;De Luca, Andrea;Di Giambenedetto, Simona
2015
Abstract
Despite not being approved in Europe as first-line therapy, the efavirenz (EFV)-containing single tablet regimen (STR) is frequently used in clinical practice in naïve patients but few data are available on this strategy. In our study, we aimed to assess the risk of EFV discontinuation in patients starting antiretroviral therapy with STR vs. nonSTR.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
